To support the mRNA- and gene signature-based analysis for TACC3 and CA, respectively, we stained TACC3 protein in breast cancer patients of all subtypes (BR1902, TissueArray) along with the centrosome marker, γ-tubulin to assess CA (Fig. 1E). Here, TACC3 is linked to breast carcinoma.